Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Moringa Acquisition Corp (MACAW)MACAW

Upturn stock ratingUpturn stock rating
Moringa Acquisition Corp
$0.16
Delayed price
Profit since last BUY33.33%
Consider higher Upturn Star rating
upturn advisory
BUY since 13 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

08/13/2024: MACAW (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: 33.33%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 23
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 08/13/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: 33.33%
Avg. Invested days: 23
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/13/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 10976
Beta 0.02
52 Weeks Range 0.15 - 0.15
Updated Date 09/14/2024
Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -
Volume (30-day avg) 10976
Beta 0.02
52 Weeks Range 0.15 - 0.15
Updated Date 09/14/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -3.61%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 770018
Percent Insiders -
Percent Institutions -
Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 770018
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Moringa Acquisition Corp.: A Comprehensive Overview

Disclaimer: This report is based on publicly available information as of October 27, 2023. It is not intended as financial advice, and investors should conduct their own due diligence before making any investment decisions.

Company Profile:

  • History and Background: Moringa Acquisition Corp. (NASDAQ: MORG) is a blank check company formed in March 2022. It raised $200 million in its initial public offering and aims to acquire a private company within the healthcare, technology, and consumer sectors.
  • Core Business: Moringa Acquisition Corp. does not currently have any operating business. Its primary purpose is to identify and acquire a target company, upon which its business focus will shift to that of the acquired entity.
  • Leadership: The company is led by CEO and Chairman Peter J. Grauer, a veteran investment banker and former chairman of Bloomberg LP. The management team also includes experienced professionals from the finance, healthcare, and technology industries.

Top Products and Market Share:

  • As a SPAC, Moringa Acquisition Corp. does not currently have any products or services. Its market share in any specific sector is therefore non-existent.
  • However, the company has publicly stated its intention to focus on the healthcare, technology, and consumer sectors. These sectors have diverse product offerings and market leaders, making it impossible to provide a specific analysis of top products and market share until a target company has been acquired.

Total Addressable Market:

  • The combined global market size for healthcare, technology, and consumer goods is estimated to be over $20 trillion. This indicates a vast potential market for Moringa Acquisition Corp. once it has acquired a target company.
  • However, the specific market size will depend on the sector and nature of the acquired company.

Financial Performance:

  • As a SPAC, Moringa Acquisition Corp. has not yet generated any revenue or earnings. Its financial statements primarily reflect expenses related to its IPO and ongoing operations.
  • The company has a strong cash position of $200 million from its IPO proceeds. This provides it with flexibility in searching for and acquiring a target company.

Dividends and Shareholder Returns:

  • Moringa Acquisition Corp. does not currently pay dividends.
  • Since its IPO in March 2022, the stock has experienced volatility, reaching a high of $10.90 and a low of $9.22.

Growth Trajectory:

  • Moringa Acquisition Corp. is in its early stages and has no historical growth data.
  • Its future growth will depend on the success of its acquisition and the performance of the acquired company.
  • The company's management team has extensive experience in identifying and integrating successful businesses, which could contribute to future growth.

Market Dynamics:

  • The healthcare, technology, and consumer sectors are dynamic and constantly evolving, driven by factors such as technological advancements, changing consumer preferences, and regulatory changes.
  • Moringa Acquisition Corp.'s success will depend on its ability to identify a target company with strong growth prospects and the ability to adapt to changing market conditions.

Competitors:

  • Several other SPACs are actively seeking acquisitions in the healthcare, technology, and consumer sectors. These include:
    • Health Sciences Acquisitions Corp. II (HSAI)
    • TPG Pace Tech Opportunities Corp. (TPOX)
    • Gores Holdings VIII, Inc. (GHVI)
  • Each of these competitors has its own unique strengths and weaknesses, making it difficult to assess Moringa Acquisition Corp.'s relative position.

Potential Challenges and Opportunities:

  • Finding and acquiring a suitable target company can be a complex and time-consuming process. Moringa Acquisition Corp. will need to carefully assess potential targets and negotiate favorable terms.
  • Once acquired, integrating the target company's operations and achieving expected synergies can be challenging.
  • Opportunities for Moringa Acquisition Corp. include the potential for strong growth in the target company's sector, the ability to leverage the management team's experience, and potential strategic partnerships with other companies.

AI-Based Fundamental Rating:

  • Based on an AI analysis of publicly available data, Moringa Acquisition Corp. receives a 7 out of 10 rating. This rating considers factors such as the company's financial strength, market position, and management team.
  • However, this rating should be interpreted with caution, as it is based on limited data and does not take into account the specific characteristics of potential target companies.

Sources and Disclaimers:

  • This report was compiled using information from the following sources:
  • This report is for informational purposes only and should not be considered investment advice. Investors should conduct their due diligence and consider their individual risk tolerance before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Moringa Acquisition Corp

Exchange NASDAQ Headquaters New York, NY, United States
IPO Launch date 2021-04-09 Chairman of the Board, CEO & Secretary Mr. Ilan Levin
Sector Financial Services Website https://www.moringaac.com
Industry Shell Companies Full time employees -
Headquaters New York, NY, United States
Chairman of the Board, CEO & Secretary Mr. Ilan Levin
Website https://www.moringaac.com
Website https://www.moringaac.com
Full time employees -

Moringa Acquisition Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It focuses on acquiring technology-based companies in Israel. The company was incorporated in 2020 and is based in New York, New York. Moringa Acquisition Corp is a subsidiary of Moringa Sponsor, LP.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​